Investor
TRV GP VI, LLC
CIK 0001990716 · filed 2026-05-07 · SEC filing
13F book
$135.6M
Positions
3
Largest name
74.6%
Septerna, Inc. · SEPN
Est. mark
−$13M
Price effect on 3 names still held. Flow $0.
| Name | Ticker | Shares | Value | Weight | Est. mark | Change |
|---|---|---|---|---|---|---|
| Septerna, Inc. | SEPN | 4.21M | $101.2M | 74.6% | −$16.2M | Held |
| Rapport Therapeutics, Inc. | RAPP | 969.2K | $30.3M | 22.4% | $920.8K | Held |
| Tango Therapeutics, Inc. | TNGX | 194.2K | $4.06M | 3.0% | $2.34M | Held |
Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.